{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:31:37Z","timestamp":1761964297469},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:00:00Z","timestamp":1295481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00415-010-5869-9","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T11:59:28Z","timestamp":1295438368000},"page":"1169-1171","source":"Crossref","is-referenced-by-count":4,"title":["Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm"],"prefix":"10.1007","volume":"258","author":[{"given":"J\u00falia","family":"Mir\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Maj\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Boluda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Bruna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,20]]},"reference":[{"key":"5869_CR1","first-page":"181","volume-title":"WHO classification of tumours of the central nervous system","author":"DJ Brat","year":"2007","unstructured":"Brat DJ, Perry A (2007) Melanocytic lesions. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 181\u2013183"},{"key":"5869_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1006127619926","volume":"44","author":"H Oka","year":"1999","unstructured":"Oka H, Kameya T, Hata T, Kawano N, Fuji K, Yada K (1999) Leptomeningeal melanomatosis with multiple cutaneous pigmented nevi: tumor cell proliferation and malignant transformation in an autopsy case. J Neurooncol 44:41\u201345","journal-title":"J Neurooncol"},{"key":"5869_CR3","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/1097-0142(19931001)72:7<2277::AID-CNCR2820720736>3.0.CO;2-F","volume":"72","author":"M Reyes-Mugica","year":"1993","unstructured":"Reyes-Mugica M, Chou P, Byrd S, Ray V, Castelli M, Gattuso P et al (1993) Nevomelanocytic proliferations in the central nervous system of children. Cancer 72:2277\u20132285","journal-title":"Cancer"},{"key":"5869_CR4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00000478-199907000-00001","volume":"23","author":"DJ Brat","year":"1999","unstructured":"Brat DJ, Giannini C, Scheithauer BW, Burger PC (1999) Primary melanocytic neoplasms of the central nervous system. Am J Surg Pathol 23:745\u2013754","journal-title":"Am J Surg Pathol"},{"key":"5869_CR5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.1999.17.9.2745","volume":"17","author":"PB Chapman","year":"1999","unstructured":"Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS et al (1999) Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastasic melanoma. J Clin Oncol 17:2745\u20132751","journal-title":"J Clin Oncol"},{"key":"5869_CR6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"5869_CR7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","volume":"18","author":"MR Middleton","year":"2000","unstructured":"Middleton MR, Grob JJ, Aaronson N, Fierlbeck G, Tilgen W, Seiter S et al (2000) Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 18:158\u2013166","journal-title":"J Clin Oncol"},{"key":"5869_CR8","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1200\/JCO.2005.01.1551","volume":"23","author":"R Kaufmann","year":"2005","unstructured":"Kaufmann R, Spieth K, Leiter U, Mauch C, von den Driesch P, Vogt T et al (2005) Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from Dermatologic Cooperative Oncology Group. J Clin Oncol 23:9001\u20139007","journal-title":"J Clin Oncol"},{"key":"5869_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11060-005-2914-0","volume":"76","author":"M Hofmann","year":"2006","unstructured":"Hofmann M, Kiecker F, Wurm R, Schlenger L, Budach V, Sterry W et al (2006) Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol 76:59\u201364","journal-title":"J Neurooncol"},{"key":"5869_CR10","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2004.11.044","volume":"22","author":"SS Agarwala","year":"2004","unstructured":"Agarwala SS, Kirkwood JM, Gore M, Dreno B, Thatcher N, Czarnetski B et al (2004) Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 22:2101\u20132107","journal-title":"J Clin Oncol"},{"key":"5869_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00008390-200204000-00011","volume":"12","author":"MJ Paul","year":"2002","unstructured":"Paul MJ, Summers Y, Calvert AH, Rustin G, Brampton MH, Thatcher N et al (2002) Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res 12:175\u2013178","journal-title":"Melanoma Res"},{"key":"5869_CR12","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/cncr.21081","volume":"103","author":"WJ Hwu","year":"2005","unstructured":"Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J et al (2005) Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. Cancer 103:2590\u20132597.7","journal-title":"Cancer"},{"key":"5869_CR13","first-page":"387","volume":"28","author":"G Martin-Blondel","year":"2009","unstructured":"Martin-Blondel G, Rousseau A, Boch AL, Cacoub P, S\u00e8ne D (2009) Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature. Clin Neuropathol 28:387\u2013394","journal-title":"Clin Neuropathol"},{"issue":"Suppl 2","key":"5869_CR14","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","volume":"36","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain MC, Glantz M, Groves MD, Wilson WH (2009) Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol 36(Suppl 2):S35\u2013S45","journal-title":"Semin Oncol"},{"key":"5869_CR15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2006.00597.x","volume":"47","author":"L Ngo","year":"2006","unstructured":"Ngo L, Nei M, Glass J (2006) Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma. Epilepsia 47:1237\u20131238","journal-title":"Epilepsia"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5869-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5869-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:07:09Z","timestamp":1559952429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5869-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,20]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["5869"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5869-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,20]]}}}